Lavtepatil, Sonam
Ghosh, Soumitra
Article History
Received: 16 May 2021
Accepted: 29 April 2022
First Online: 13 May 2022
Declarations
:
: All methods were performed in accordance with the relevant guidelines and regulations. The study protocol was approved by the School of Health Systems Studies, Tata Institute of Social Sciences, Mumbai. Besides, the permission to conduct the study was obtained from Bureau of Public Pharmaceutical Undertakings (BPPI), Department of Pharmaceuticals, Government of India. The informed written consent of study participants’ including the pharmacists of surveyed PMBJP outlets was obtained prior to conducting interviews and reviewing stock records.
: Not applicable.
: The authors declare that they have no competing interests.